Moreover, tumors with high TREM2 expression tend to have a higher proportion of M2-like TAMs, which, along with TREM2 + LAM-like cells, exert synergistic immunosuppressive effects to drive HCC progression. The gene discussed is TREM2; the disease is hepatocellular carcinoma.